Just now, a major futures index was released!

The Resonance Between Derivatives and ETFs

Gelonghui FinanceNov 28 15:19

Express News | The entire pharmaceutical sector in the Hong Kong stock market has strengthened, with the Hang Seng Pharmaceutical ETF rising over 2%.

BreakingsNov 26 11:08

Intelligent Market Analysis of Hong Kong Stocks | Price Hike Themes Dominate the Market, Technology Stocks Begin to Show Signs of Recovery

Today, both markets opened lower but surged significantly, with the Shanghai Composite Index breaking through the 4,000-point mark to reach a ten-year high. The Hang Seng Index also surpassed the 27,000-point level, coming within less than 300 points of this year's peak, while trading volume exceeded 270 billion Hong Kong dollars.

Zhitong FinanceNov 13 20:15

The U.S. government shutdown ends! Gold and innovative drugs rally together, with Hang Seng Medicine ETF and Gold Stock ETF surging over 3%. The CSOP Gold ETF, which has seen 10 consecutive inflows, rose by 1.4%.

Gelonghui, November 13th | The gold and innovative pharmaceuticals sectors continued their recent upward momentum today. The Huaxia Gold ETF rose by 1.41%, while the more elastic Gold Stock ETF surged by 3.12%, and the Hang Seng Pharmaceuticals ETF increased by 3.36%, marking two consecutive days of gains. News highlights: ① Overnight spot gold continued to rebound to USD 4,196.54 per ounce, nearing the USD 4,200 mark. The latest reports indicate that U.S. President Trump signed a temporary federal funding bill passed by both chambers of Congress at the White House, ending the longest government shutdown in history, which had lasted for 43 days. This is expected to ease the recent tightness in dollar liquidity.

Gelonghui FinanceNov 13 11:44

The innovative drug sector in Hong Kong's stock market rebounded, with the Hang Seng Pharmaceuticals ETF rising by 2.8%. The Hang Seng SOE Dividend ETF surged over 11% starting from September 26.

Gelonghui, November 12 | The Hong Kong stock innovative drug sector opened high and continued to rise, with 3SBio and BeiGene up by 6%. DyNAbtx and Akeso rose by 4.36% and 3.72%, respectively, driving the largest-scale Hang Seng Medical ETF tracking these stocks to increase by 2%. The dividend sector extended its upward trend, with the Hong Kong SOE Dividend ETF rising over 1%, accumulating an 11% gain from September 26 to date. In terms of news: ① BeiGene reported total revenue of $1.4 billion in Q3, a robust year-over-year increase of 41%, setting a record high for the same period. Its GAAP net profit for the period was $125 million, reversing a year-over-year loss. ② On the industry front, last week's updates on the National Essential Medicines List for 2025...

Gelonghui FinanceNov 12 10:14

A Comprehensive Overview of the Core Directions of the 15th Five-Year Plan and Related ETFs!

Historic transformation

Gelonghui FinanceOct 30 17:42